MicroStrategy jumps as company set to join Nasdaq 100 index
** MicroStrategy MSTR.O shares rise by 6.1% in premarket trading as the company is set to join the tech-focused Nasdaq 100 index
** Other entrants to Nasdaq 100 along with MSTR: Palantir PLTR.O and Axon Enterprise AXON.O up 1% and 3.1%, respectively, in premarket trading
** Companies to be removed from the index fall: Illumina ILMN.O down 1.2%, Super Micro Computer SMCI.O down 11.8% and Moderna MRNA.O down 0.6%
** Nasdaq 100 index will now gain indirect exposure to bitcoin via MSTR, which holds $44 bln worth of the cryptocurrency on its balance sheet
** MSTR has more than doubled its bitcoin holdings this year through equity and debt deals
** Company's market capitalization rose to more than $100 bln based on the latest premarket share price, more than twice the value of its bitcoin stockpile
** The reconstituted index will begin trading on Dec. 23
** As of last close, MSTR up more than six-fold, while PLTR has gained more than four-fold and AXON has more than doubled, YTD
Reporting by Sukriti Gupta in Bengaluru
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
